Abstract
摘要
相似文献
1
Lithium the lifesaver.
Harv Ment Health Lett. 2004 Feb;20(8):7.
2
Hard outcomes: clinical trials to reduce suicide.硬性结果：降低自杀率的临床试验。
Am J Psychiatry. 2011 Oct;168(10):1009-11. doi: 10.1176/appi.ajp.2011.11081250.
3
Differential lithium efficacy in reducing suicidal behaviors compared with suicidal thoughts.与自杀念头相比，锂盐在降低自杀行为方面的疗效差异。
Am J Psychiatry. 2012 Jan;169(1):98-9; author reply 99. doi: 10.1176/appi.ajp.2011.11081220.
4
Additional effect size measures helpful in understanding lithium and valproate trial results.有助于理解锂盐和丙戊酸盐试验结果的其他效应量指标。
Am J Psychiatry. 2012 Jan;169(1):97-8; author reply 99. doi: 10.1176/appi.ajp.2011.11081263.
5
Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder.锂盐和丙戊酸盐治疗期间的自杀行为：50000 例双相情感障碍患者 8 年的前瞻性个体内研究。
Am J Psychiatry. 2017 Aug 1;174(8):795-802. doi: 10.1176/appi.ajp.2017.16050542. Epub 2017 Jun 9.
6
Predictors of response to mood stabilizers.心境稳定剂反应的预测因素。
J Clin Psychopharmacol. 1996 Apr;16(2 Suppl 1):24S-31S. doi: 10.1097/00004714-199604001-00004.
7
Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.双相情感障碍的药物治疗与自杀行为。第一部分：锂盐、丙戊酸和卡马西平。
J Affect Disord. 2007 Nov;103(1-3):5-11. doi: 10.1016/j.jad.2007.05.019. Epub 2007 Jul 12.
8
[Not Available].[无可用内容]。
Pharmacopsychiatry. 2017 Nov;50(6):270. doi: 10.1055/s-0043-109240. Epub 2017 May 8.
9
Outcome in the pharmacologic treatment of bipolar disorder.
J Clin Psychopharmacol. 1996 Apr;16(2 Suppl 1):15S-23S. doi: 10.1097/00004714-199604001-00003.
10
Mania.
Lancet. 1997 Jul 26;350(9073):292. doi: 10.1016/S0140-6736(05)62258-1.
Zotero 插件